Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website. 

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Karmanos Cancer Institute Recognizes Four Cancer Awareness Months During September

The  Barbara Ann Karmanos Cancer Institute , along with cancer centers and other organizations across the nation, recognizes and promotes awa...

Read More

IN THE NEWS: Misconceptions About Cancer Clinical Trials and How to Overcome Them

Clinical Leader Patients may not be the only ones who may be apprehensive about participating in clinical trials; some physicians may be hesitant ...

Read More

Karmanos, WSU Researcher Receives NIH Award to Explore Socio-genomic Factors of Local Endometrial Cancer Survival Rates

The National Cancer Institute of the National Institutes of Health has awarded Anna Gottschlich, Ph.D., M.P.H., member of the Population Studies a...

Read More
News

105.9 KISS FM | Getting a Second Opinion at Karmanos

Listen Now

WJR | Karmanos Cancer Institute Continues Its Community Education Series

Listen Now

WXYT 97.1 The Ticket | ‘Get a Mammogram’

Listen Now
View All Podcasts